参考文献/References:
[1] SUNG H, FERLAY J, SIEGEL R L, et al. Globalcancer statistics 2020: GLOBOCAN estimates ofincidence and mortality worldwide for 36 cancers in185 countries[J]. CA-A Cancer Journal for Clinicians,2021, 71(3): 209-249.
[2] CAO Wei, CHEN Hongda, YU Yiwei, et al. Changingprofiles of cancer burden worldwide and in China:asecondary analysis of the global cancer statistics2020[J]. Chinese Medical Journal, 2021, 134(7): 783-791.
[3] PRASAD D, NGUYEN M H. Epidemiology,pathogenesis, diagnosis, surveillance,and managementof hepatocellular carcinoma associated with vascularliver disease[J]. The Kaohsiung Journal of MedicalSciences, 2021, 37(5): 355-360.
[4] 吴良银, 李文丽, 刘俊. 肝细胞癌患者生存预后相关长链非编码RNA(LncRNA) 的生物信息学分析[J].现代检验医学杂志,2019,34(4):18-21.WU Liangyin, LI Wenli, LIU Jun. Bioinformaticsanalysis of long-chain non-coding RNA related tosurvival and prognosis in patients with hepatocellularcarcinoma [J]. Journal of Modern LaboratoryMedicine,2019,34(4):18-21.
[5] 张鑫浩, 张涛元, 李俏, 等. 基于GEO 芯片数据的肝癌关键生物标志物的筛选与鉴定及生物信息学分析[J]. 现代检验医学杂志,2020,35(4):26-31.ZHANG Xinhao, ZHANG Taoyuan, LI Qiao, et al.Screening, identification and bioinformatics analysisof Key biomarkers for hepatocellular carcinoma basedon GEO chip data[J]. Journal of Modern LaboratoryMedicine,2020,35(4):26-31.
[6] PENG Cheng,HAN Siyu,ZHANG Hui,et al. RPITER:A hierarchical deep learning framework for ncRNAproteininteraction prediction[J]. International Journalof Molecular Sciences, 2019, 20(5): 1070.
[7] MCCABE E M, RASMUSSEN T P. lncRNAinvolvement in cancer stem cell function and epithelialmesenchymaltransitions[J]. Seminars in CancerBiology, 2020, S1044-579X(20): 30272.
[8] XU Shaohua, BO Yuhong, MA Hanchen, et al. lncRNALINC00473 promotes proliferation, migration, invasionand inhibition of apoptosis of non-small cell lungcancer cells by acting as a sponge of miR-497-5p[J].Oncology Letters, 2021, 21(6) : 429.
[9] FANG Kun, XU Zhengjie, JIANG Suxiao, et al.LncRNA FGD5AS1 promotes breast cancer progressionby regulating the hsamiR1955p/NUAK2 axis[J].Molecular Medicine Reports, 2021, 23(6): 12099.
[10] LUO Jun, ZHENG Jiaping, HAO Weiyuan, et al.LncRNA PCAT6 facilitates cell proliferation andinvasion via regulating the miR-326/hnRNPA2B1axis in liver cancer[J]. Oncology Letters, 2021, 21(6):12732.
[11] TAN Weixi, SUN Ge, SHANGGUAN Mengyuan, etal. Novel role of lncRNA CHRF in cisplatin resistanceof ovarian cancer is mediated by miR-10b inducedEMT and STAT3 signaling[J]. Scientific Reports, 2020,10(1): 14768.
[12] HE Bo, PENG Feng, LI Wei, et al. Interaction oflncRNA-MALAT1 and miR-124 regulates HBxinducedcancer stem cell properties in HepG2 throughPI3K/Akt signaling[J].Journal of Cellular Biochemistry,2019, 120(suppl 4): 26823.
[13] LI Meiling, MENG Fuxue , LU Quanyi. Expressionprofile screening and bioinformatics analysis ofcircRNA, lncRNA, and mRNA in acute myeloidleukemia drug-resistant cells[J]. Turkish Journal ofHaematology, 2020, 37(2) : 104-110.
[14] LIU Zhaoming, LI Zhen, XU Binghui, et al. Longnoncoding RNA PRR34-AS1 aggravates theprogression of hepatocellular carcinoma by adsorbingmicroRNA-498 and thereby upregulating FOXO3[J].Cancer Management and Research, 2020, 12: 10749-10762.
[15] YANG Xuejing,SONG Dong,ZHANG Junping, et al.PRR34-AS1 sponges miR-498 to facilitate TOMM20and ITGA6 mediated tumor progression in HCC[J].Experimental and Molecular Pathology, 2021, 120:104620.
[16] FANG Hua, ZHANG Fangxiang,LI Huafeng,et al.PRR34‐AS1 overexpression promotes protection ofpropofol pretreatment against ischemia/reperfusioninjury in a mouse model after total knee arthroplastyvia blockade of the JAK1‐dependent JAK‐STATsignaling pathway[J]. Journal of Cellular Physiology,2020, 235(3): 2545–2556.
[17] BRIDGES M C, DAULAGALA A C, KOURTIDIS A.LNCcation: lncRNA localization and function[J]. TheJournal of Cell Biology, 2021, 220(2): e202009045.
[18] AKKIPEDDI S, VELLECA A J, CARONE D M.Probing the function of long noncoding RNAs in thenucleus[J]. Chromosome Research, 2020, 28(1): 87-110.
[19] GAO Xue, QIN Tao, MAO Jun, et al. PTENP1/miR-20a/PTEN axis contributes to breast cancer progressionby regulating PTEN via PI3K/AKT pathway[J]. Journalof Experimental & Clinical Cancer Research, 2019,38(1): 256.
[20] WANG Chaoyang, ZI Hao, WANG Yinghui, et al.LncRNA CASC15 promotes tumour progressionthrough SOX4/Wnt/β-catenin signalling pathway inhepatocellular carcinoma[J]. Artificial Cells, 2020,48(1): 763-769.
[21] 杨昕, 唐哲, 张鹏, 等.JAK/STAT 信号通路在肺癌中的研究进展[J]. 中国肺癌杂志,2019,22(1):45-51．YANG Xin, TANG Zhe, ZANG Peng, et al. Researchadvances of JAK/STAT signaling pathwayin lung cancer[J]. Chinese Journal of Lung Cancer,2019,22(1):45-51.
[22] TOH T B, LIM J J, HOOI L, et al. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-drivenhepatocellular carcinoma[J]. Journal of Hepatology,2020, 72(1): 104-118.
[23] LI Yaping, SUN Weixuan, HAN Ning, et al. Curcumininhibits proliferation, migration, invasion and promotesapoptosis of retinoblastoma cell lines throughmodulation of miR-99a and JAK/STAT pathway[J].BMC Cancer, 2018, 18(1): 1230.
[24] WANG Jue, ZHOU Maojun, JIN Xin, et al. Glycochenodeoxycholateinduces cell survival and chemoresistancevia phosphorylation of STAT3 at Ser727 site inHCC[J]. Journal of Cellular Physiology, 2020, 235(3):2557-2568.
[25] OWEIDA A J, DARRAGH L, PHAN A, et al. STAT3modulation of regulatory T cells in response toradiation therapy in head and neck cancer[J]. Journalof the National Cancer Institute, 2019, 111(12): 1339-1349.
[26] ZHANG Xin, HU Bo, SUN Yunfan, et al. Arsenictrioxide induces differentiation of cancer stem cellsin hepatocellular carcinoma through inhibition ofLIF/JAK1/STAT3 and NF-kB signaling pathwayssynergistically[J]. Clinical and Translational Medicine,2021, 11(2): e335.
[27] SU Chao, WANG Wenchang, WANG Cunchuan. IGF-1-induced MMP-11 expression promotes the proliferationand invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway[J]. Oncology Letters, 2018,15(5): 7000-7006.
[28] ZHOU Y, XU X M, FENG Y. MiR-769-5p inhibitscancer progression in oral squamous cell carcinoma bydirectly targeting JAK1/STAT3 pathway[J]. Neoplasma,2020, 67(3): 528-536.
[29] YANG Lixue, XUE Hui, SUN Yanfu, et al. CircularRNA-9119 protects hepatocellular carcinoma cells fromapoptosis by intercepting miR-26a/JAK1/STAT3 signaling[J]. Cell Death & Disease, 2020, 11(7): 605.
[30] ABDEL-WAHAB B A, ALI F, ALKAHTANI S A,et al. Hepatoprotective effect of rebamipide againstmethotrexate-induced hepatic intoxication: roleof Nrf2/GSK-3β, NF-κβ-p65/JAK1/STAT3,and PUMA/Bax/Bcl-2 signaling pathways[J].Immunopharmacology and Immunotoxicology, 2020,42(5): 493-503.
[31] REDDY D, KUMAVATH R, GHOSH P, et al.Lanatoside C induces G2/M cell cycle arrest andsuppresses cancer cell growth by attenuating MAPK,Wnt, JAK-STAT, and PI3K/AKT/mTOR signalingpathways[J]. Biomolecules, 2019, 9(12): 792.
相似文献/References:
[1]王芳胜,熊敦勇,寇辉,等.血清AFP，CEA，CA-199与TAP在肝癌诊断中的应用价值[J].现代检验医学杂志,2015,30(05):148.[doi:10.3969/j.issn.1671-7414.2015.05.047]
WANG Fang-sheng,XIONG Dun-yong,KOU Hui,et al.Application Value of Serum AFP，CEA，CA-199
and TAP in the Diagnosis of Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(06):148.[doi:10.3969/j.issn.1671-7414.2015.05.047]
[2]刘冲,唐浩,邓霖,等.血清miRNA-186,miRNA-30c在肝细胞性癌中诊断价值的研究[J].现代检验医学杂志,2016,31(06):44.[doi:10.3969/j.issn.1671-7414.2016.06.012]
LIU Chong,TANG Hao,DENG Lin,et al.Research of Diagnostic Application of Serum miRNA-186 and miRNA-30c in Patients with Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2016,31(06):44.[doi:10.3969/j.issn.1671-7414.2016.06.012]
[3]王 蓉,蔡高涛,钟小青,等.血清AFP-L3和GP-73联合检测对原发性肝癌诊断的Meta分析[J].现代检验医学杂志,2019,34(02):72.[doi:10.3969/j.issn.1671-7414.2019.02.019]
WANG Rong,CAI Gao-tao,ZHONG Xiao-qing,et al.Meta Analysis of Combined Detection of Serum AFP-L3and GP-73 in Diagnosis of Primary Liver Cancer[J].Journal of Modern Laboratory Medicine,2019,34(06):72.[doi:10.3969/j.issn.1671-7414.2019.02.019]
[4]张鑫浩,张涛元,李 俏,等.基于GEO 芯片数据的肝癌关键生物标志物的筛选与鉴定及生物信息学分析[J].现代检验医学杂志,2020,35(04):26.[doi:10.3969/j.issn.1671-7414.2020.04.007]
ZHANG Xin-hao,ZHANG Tao-yuan,LI Qiao,et al.Screening, Identification and Bioinformatics Analysis of Key Biomarkers for Hepatocellular Carcinoma Based on GEO Chip Data[J].Journal of Modern Laboratory Medicine,2020,35(06):26.[doi:10.3969/j.issn.1671-7414.2020.04.007]
[5]王楷翔a,曹 明a,陈 晖b,等.HCV感染患者血清miR-199和miR-483水平表达及其临床价值[J].现代检验医学杂志,2021,36(05):58.[doi:10.3969/j.issn.1671-7414.2021.05.013]
WANG Kai-xianga,CAO Minga,CHEN Huib,et al.Expression and Clinical Value of Serum miR-199 and miR-483 inPatients with HCV Infection[J].Journal of Modern Laboratory Medicine,2021,36(06):58.[doi:10.3969/j.issn.1671-7414.2021.05.013]
[6]陈 偲,王 颖a,谢生茂,等.GPRC5A对肝癌细胞增殖、凋亡和氧化应激的影响及作用机制探讨[J].现代检验医学杂志,2021,36(06):10.[doi:10.3969/j.issn.1671-7414.2021.06.003]
CHEN Si,WANG Ying,WU Jian-jun,et al.Effects of GPRC5A on Proliferation, Apoptosis and Oxidative Stress of Hepatocellular Carcinoma Cells and Its Mechanism[J].Journal of Modern Laboratory Medicine,2021,36(06):10.[doi:10.3969/j.issn.1671-7414.2021.06.003]
[7]吴 琼,郑志存.UBE2T对肝癌细胞增殖、克隆形成及细胞周期的影响及机制研究[J].现代检验医学杂志,2022,37(02):115.[doi:10.3969/j.issn.1671-7414.2022.02.024]
WU Qiong,CHENG Zhi-cun.Effects of UBE2T on Proliferation, Clone Formation and Cell Cycle of Hepatocellular Carcinoma Cells and Its Molecular Mechanism[J].Journal of Modern Laboratory Medicine,2022,37(06):115.[doi:10.3969/j.issn.1671-7414.2022.02.024]
[8]王俊霞a,贾如江b,霍浩然b,等.肝癌患者血清AHSG，NF-κB表达水平与肝动脉化疗栓塞术预后的相关性研究[J].现代检验医学杂志,2022,37(02):126.[doi:10.3969/j.issn.1671-7414.2022.02.026]
WANG Jun-xiaa,JIA Ru-jiangb,HUO Hao-ranb,et al.Correlation between Serum AHSG, NF-κB Expression Levels and Prognosis of Hepatic Artery Chemoembolization in Patients with Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2022,37(06):126.[doi:10.3969/j.issn.1671-7414.2022.02.026]